Evidence map›Paper›PMID 39771588›Full record

ArticlePharmaceutics2024

A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel.

Raiane Aparecida Dos Santos Machado, Raoni Pais Siqueira, Fernanda Cardoso da Silva, André Carlos Pereira de Matos, Dayanne Silva Borges, Gislaine Gonçalves Rocha, Thais Cristina Prado de Souza, Rafael Aparecido Carvalho Souza, Clayton Rodrigues de Oliveira, Antônio G Ferreira and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. {ZnMolecules (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Raiane Aparecida Dos Santos MachadoLaboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas 38700-002, MG, Brazil.ORCID 0009-0003-6665-1228
Raoni Pais SiqueiraLaboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas 38700-002, MG, Brazil.
Fernanda Cardoso da SilvaLaboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas 38700-002, MG, Brazil.ORCID 0000-0001-8078-6282
André Carlos Pereira de MatosLaboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas 38700-002, MG, Brazil.ORCID 0000-0002-6838-5889
Dayanne Silva BorgesLaboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas 38700-002, MG, Brazil.
Gislaine Gonçalves RochaLaboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas 38700-002, MG, Brazil.ORCID 0000-0002-5483-3986
Thais Cristina Prado de SouzaInstitute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, MG, Brazil.ORCID 0009-0002-0817-2141
Rafael Aparecido Carvalho SouzaInstitute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, MG, Brazil.ORCID 0000-0003-3472-4026
Clayton Rodrigues de OliveiraDepartment of Chemistry, Federal University of São Carlos, Rodovia Washington Luís, km 235, São Carlos 13565-905, SP, Brazil.
Antônio G FerreiraDepartment of Chemistry, Federal University of São Carlos, Rodovia Washington Luís, km 235, São Carlos 13565-905, SP, Brazil.
Pedro Ivo da Silva MaiaBioactive Compounds Development Research Group, Federal University of Triangulo Mineiro, Av. Dr. Randolfo Borges 1400, Uberaba 38025-440, MG, Brazil.ORCID 0000-0003-4699-9481
Victor Marcelo DeflonSão Carlos Institute of Chemistry, University of São Paulo, São Carlos 13560-970, SP, Brazil.
Carolina Gonçalves OliveiraInstitute of Chemistry, Federal University of Uberlândia, Uberlândia 38400-902, MG, Brazil.ORCID 0000-0001-6030-6034
Thaise Gonçalves AraújoLaboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlândia, Patos de Minas 38700-002, MG, Brazil.ORCID 0000-0002-7593-1403

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 305328/2022-0 - T.G.A., 403193/2022-2, 408926/2021-0 and 311747/2023-0FAPEMIG APQ-00741-24FAPEMIG APQ-00834-24FAPEMIG APQ-01164-22FAPEMIG CBB-APQ 03613-17FAPEMIG RED-00116-23FAPEMIG REMITRIBIC RED-00031-21
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerchemotherapyMDA-MB-231Zinc(II)

Identifiers

PMID39771588
PMCPMC11676115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.